A detailed history of Quaker Wealth Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Quaker Wealth Management, LLC holds 6 shares of BIIB stock, worth $924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 4 50.0%
Holding current value
$924
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

BUY
$113.38 - $135.49 $680 - $812
6 New
6 $0

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Quaker Wealth Management, LLC Portfolio

Follow Quaker Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quaker Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quaker Wealth Management, LLC with notifications on news.